The latest study on Meningococcal Vaccines Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Meningococcal Vaccines Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Meningococcal Vaccines and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Meningococcal Vaccines Market Analysis By Type Segment:
Menactra
Menomune
Meningococcal Vaccines Market Analysis By Application Segment:
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Meningococcal Vaccines Market Analysis By Regions (Countries):
The Meningococcal Vaccines Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Meningococcal Vaccines Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Meningococcal Vaccines Market:
Meningococcal Vaccines market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Meningococcal Vaccines Market
What is the expected Market size and growth rate of the Meningococcal Vaccines market for the forecast period
Where is the largest and fastest growing market for Meningococcal Vaccines market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Meningococcal Vaccines market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Meningococcal Vaccines Market status and future forecast.
To present the key Meningococcal Vaccines Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Meningococcal Vaccines Market Size Growth Rate by Type (2021-2027)
1.3.2 Menactra
1.3.3 Menomune
1.4 Market Segment by Application
1.4.1 Global Meningococcal Vaccines Market Share by Application (2021-2027)
1.4.2 Pneumonia
1.4.3 Meningitis
1.4.4 Bacteremia
1.4.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Vaccines Market Size
2.1.1 Global Meningococcal Vaccines Revenue 2016-2027
2.1.2 Global Meningococcal Vaccines Sales 2016-2027
2.2 Meningococcal Vaccines Growth Rate by Regions
2.2.1 Global Meningococcal Vaccines Sales by Regions 2016-2020
2.2.2 Global Meningococcal Vaccines Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Meningococcal Vaccines Sales by Manufacturers
3.1.1 Meningococcal Vaccines Sales by Manufacturers 2016-2020
3.1.2 Meningococcal Vaccines Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Meningococcal Vaccines Revenue by Manufacturers (2016-2020)
3.2.2 Meningococcal Vaccines Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Meningococcal Vaccines Price by Manufacturers
3.4 Key Manufacturers Meningococcal Vaccines Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Meningococcal Vaccines Market
3.6 Key Manufacturers Meningococcal Vaccines Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Menactra Sales and Revenue (2016-2020)
4.1.2 Menomune Sales and Revenue (2016-2020)
4.2 Global Meningococcal Vaccines Sales Market Share by Type
4.3 Global Meningococcal Vaccines Revenue Market Share by Type
4.4 Meningococcal Vaccines Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Meningococcal Vaccines Sales by Application
6 United States
6.1 United States Meningococcal Vaccines Breakdown Data by Company
6.2 United States Meningococcal Vaccines Breakdown Data by Type
6.3 United States Meningococcal Vaccines Breakdown Data by Application
7 European Union
7.1 European Union Meningococcal Vaccines Breakdown Data by Company
7.2 European Union Meningococcal Vaccines Breakdown Data by Type
7.3 European Union Meningococcal Vaccines Breakdown Data by Application
8 China
8.1 China Meningococcal Vaccines Breakdown Data by Company
8.2 China Meningococcal Vaccines Breakdown Data by Type
8.3 China Meningococcal Vaccines Breakdown Data by Application
9 Rest of World
9.1 Rest of World Meningococcal Vaccines Breakdown Data by Company
9.2 Rest of World Meningococcal Vaccines Breakdown Data by Type
9.3 Rest of World Meningococcal Vaccines Breakdown Data by Application
9.4 Rest of World Meningococcal Vaccines Breakdown Data by Countries
9.4.1 Rest of World Meningococcal Vaccines Sales by Countries
9.4.2 Rest of World Meningococcal Vaccines Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.1.4 Meningococcal Vaccines Product Introduction
10.1.5 GlaxoSmithKline Recent Development
10.2 JN-International Medical
10.2.1 JN-International Medical Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.2.4 Meningococcal Vaccines Product Introduction
10.2.5 JN-International Medical Recent Development
10.3 Novartis International
10.3.1 Novartis International Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.3.4 Meningococcal Vaccines Product Introduction
10.3.5 Novartis International Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.4.4 Meningococcal Vaccines Product Introduction
10.4.5 Sanofi Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.5.4 Meningococcal Vaccines Product Introduction
10.5.5 Pfizer Recent Development
10.6 Baxter International
10.6.1 Baxter International Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Meningococcal Vaccines
10.6.4 Meningococcal Vaccines Product Introduction
10.6.5 Baxter International Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Meningococcal Vaccines Sales Channels
11.2.2 Meningococcal Vaccines Distributors
11.3 Meningococcal Vaccines Customers
12 Market Forecast
12.1 Global Meningococcal Vaccines Sales and Revenue Forecast 2021-2027
12.2 Global Meningococcal Vaccines Sales Forecast by Type
12.3 Global Meningococcal Vaccines Sales Forecast by Application
12.4 Meningococcal Vaccines Forecast by Regions
12.4.1 Global Meningococcal Vaccines Sales Forecast by Regions 2021-2027
12.4.2 Global Meningococcal Vaccines Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Meningococcal Vaccines Product Picture
Table Meningococcal Vaccines Key Market Segments
Table Major Manufacturers Meningococcal Vaccines Covered in This Report
Table Global Meningococcal Vaccines Market Size Growth Rate by Type 2021-2027 (K Units) & (Million US$)
Figure Global Meningococcal Vaccines Sales Market Shar by Type 2016-2027
Figure Menactra Figures
Table Major Manufacturers of Menactra
Figure Menomune Figures
Table Major Manufacturers of Menomune
Table Global Meningococcal Vaccines Market Share by Application 2021-2027 (K Units)
Figure Pneumonia Use Case
Figure Meningitis Use Case
Figure Bacteremia Use Case
Figure Others (Arthritis, Conjunctivitis, Urethritis) Use Case
Figure Meningococcal Vaccines Report Years Considered
Figure Global Meningococcal Vaccines Market Size 2016-2027 (Million US$)
Figure Global Meningococcal Vaccines Sales 2016-2020 (K Units)
Table Global Meningococcal Vaccines Market Size by Regions 2016-2020 (K Units) & (Million US$)
Table Global Meningococcal Vaccines Sales by Regions 2016-2020 (K Units)
Table Global Meningococcal Vaccines Sales Market Share by Regions 2016-2020
Figure Global Meningococcal Vaccines Sales Market Share by Regions 2016-2020
Figure Global Meningococcal Vaccines Sales Market Share by Regions in 2020
Table Global Meningococcal Vaccines Revenue by Regions 2016-2020 (Million US$)
Table Global Meningococcal Vaccines Revenue Market Share by Regions 2016-2020
Figure Global Meningococcal Vaccines Revenue Market Share by Regions 2016-2020
Figure Global Meningococcal Vaccines Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Meningococcal Vaccines Sales by Manufacturers (2016-2020) (K Units)
Table Global Meningococcal Vaccines Sales Share by Manufacturers (2016-2020)
Figure Global Meningococcal Vaccines Sales Share by Manufacturers in 2020
Table Meningococcal Vaccines Revenue by Manufacturers (2016-2020) (Million USD)
Table Meningococcal Vaccines Revenue Share by Manufacturers (2016-2020)
Figure Meningococcal Vaccines Value Share by Manufacturers in 2020
Table Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Meningococcal Vaccines Price (2016-2020) (USD/Unit)
Table Key Manufacturers Meningococcal Vaccines Plants/Factories Distribution
Table Key Manufacturers Meningococcal Vaccines Area Served
Table Date of Key Manufacturers Enter into Meningococcal Vaccines Market
Table Key Manufacturers Meningococcal Vaccines Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Menactra Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Menomune Sales and Revenue (2016-2020) (K Units) & (Million US$)
Table Global Meningococcal Vaccines Sales by Type (2016-2020) (K Units)
Table Global Meningococcal Vaccines Sales Share by Type (2016-2020)
Figure Global Meningococcal Vaccines Sales Market Share by Type (2016-2020)
Figure Global Meningococcal Vaccines Sales Market Share by Type in 2020
Table Global Meningococcal Vaccines Revenue by Type (2016-2020) (Million US$)
Table Global Meningococcal Vaccines Revenue Share by Type (2016-2020)
Figure Global Meningococcal Vaccines Revenue Market Share by Type (2016-2020)
Figure Global Meningococcal Vaccines Revenue Market Share by Type in 2020
Table Meningococcal Vaccines Price by Type 2016-2020 (USD/Unit)
Table Global Meningococcal Vaccines Sales by Application (2016-2020) (K Units)
Table Global Meningococcal Vaccines Sales Share by Application (2016-2020)
Figure Global Sales Meningococcal Vaccines Market Share by Application (2016-2020)
Figure Global Sales Meningococcal Vaccines Market Share by Application (2016-2020)
Figure United States Meningococcal Vaccines Sales Growth Rate 2016-2020 (K Units)
Figure United States Meningococcal Vaccines Revenue Growth Rate 2016-2020 (Million US$)
Table United States Meningococcal Vaccines Sales by Company (2016-2020) (K Units)
Table United States Meningococcal Vaccines Sales Market Share by Company (2016-2020)
Figure United States Meningococcal Vaccines Sales Market Share by Company in 2020
Table United States Meningococcal Vaccines Sales by Type (2016-2020) (K Units)
Table United States Meningococcal Vaccines Sales Market Share by Type (2016-2020)
Figure United States Meningococcal Vaccines Market Share by Type in 2020
Table United States Meningococcal Vaccines Sales by Application (2016-2020) (K Units)
Table United States Meningococcal Vaccines Sales Market Share by Application (2016-2020)
Figure United States Meningococcal Vaccines Market Share by Application in 2020
Figure European Union Meningococcal Vaccines Sales Growth Rate 2016-2020 (K Units)
Figure European Union Meningococcal Vaccines Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Meningococcal Vaccines Sales by Company (2016-2020) (K Units)
Table European Union Meningococcal Vaccines Sales Market Share by Company (2016-2020)
Figure European Union Meningococcal Vaccines Sales Market Share by Company in 2020
Table European Union Meningococcal Vaccines Sales by Type (2016-2020) (K Units)
Table European Union Meningococcal Vaccines Sales Market Share by Type (2016-2020)
Figure 2020 European Union Meningococcal Vaccines Market Share by Type
Table European Union Meningococcal Vaccines Sales by Application (2016-2020) (K Units)
Table European Union Meningococcal Vaccines Sales Market Share by Application (2016-2020)
Figure 2020 European Union Meningococcal Vaccines Market Share by Application
Figure China Meningococcal Vaccines Sales Growth Rate 2016-2020 (K Units)
Figure China Meningococcal Vaccines Revenue Growth Rate 2016-2020 (Million US$)
Table China Meningococcal Vaccines Sales by Company (2016-2020) (K Units)
Table China Meningococcal Vaccines Sales Market Share by Company (2016-2020)
Figure China Meningococcal Vaccines Sales Market Share by Company in 2020
Table China Meningococcal Vaccines Sales by Type (2016-2020) (K Units)
Table China Meningococcal Vaccines Sales Market Share by Type (2016-2020)
Figure China Meningococcal Vaccines Market Share by Type in 2020
Table China Meningococcal Vaccines Sales by Application (2016-2020) (K Units)
Table China Meningococcal Vaccines Sales Market Share by Application (2016-2020)
Figure China Meningococcal Vaccines Market Share by Application in 2020
Figure Rest of World Meningococcal Vaccines Sales Growth Rate 2016-2020 (K Units)
Figure Rest of World Meningococcal Vaccines Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Meningococcal Vaccines Sales by Company (2016-2020) (K Units)
Table Rest of World Meningococcal Vaccines Sales Market Share by Company (2016-2020)
Figure Rest of World Meningococcal Vaccines Sales Market Share by Company in 2020
Table Rest of World Meningococcal Vaccines Sales by Type (2016-2020) (K Units)
Table Rest of World Meningococcal Vaccines Sales Market Share by Type (2016-2020)
Figure Rest of World Meningococcal Vaccines Market Share by Type in 2020
Table Rest of World Meningococcal Vaccines Sales by Application (2016-2020) (K Units)
Table Rest of World Meningococcal Vaccines Sales Market Share by Application (2016-2020)
Figure Rest of World Meningococcal Vaccines Market Share by Application in 2020
Table Rest of World Meningococcal Vaccines Sales by Countries (2016-2020) (K Units)
Table Rest of World Meningococcal Vaccines Sales Market Share by Countries (2016-2020)
Figure Rest of World Meningococcal Vaccines Sales Market Share by Countries in 2020
Table Rest of World Meningococcal Vaccines Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Meningococcal Vaccines Revenue Market Share by Countries (2016-2020)
Figure Rest of World Meningococcal Vaccines Revenue Market Share by Countries in 2020
Figure Japan Meningococcal Vaccines Sales Growth Rate (2016-2020) (K Units)
Figure Japan Meningococcal Vaccines Revenue Growth Rate (2016-2020) (K Units)
Figure Korea Meningococcal Vaccines Sales Growth Rate (2016-2020) (K Units)
Figure Korea Meningococcal Vaccines Revenue Growth Rate (2016-2020) (K Units)
Figure India Meningococcal Vaccines Sales Growth Rate (2016-2020) (K Units)
Figure India Meningococcal Vaccines Revenue Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Meningococcal Vaccines Sales Growth Rate (2016-2020) (K Units)
Figure Southeast Asia Meningococcal Vaccines Revenue Growth Rate (2016-2020) (K Units)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table GlaxoSmithKline Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table GlaxoSmithKline Meningococcal Vaccines Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table JN-International Medical Company Details
Table JN-International Medical Description and Business Overview
Table JN-International Medical Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table JN-International Medical Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table JN-International Medical Meningococcal Vaccines Sales Market Share in Global Market
Table JN-International Medical Recent Development
Table Novartis International Company Details
Table Novartis International Description and Business Overview
Table Novartis International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Novartis International Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table Novartis International Meningococcal Vaccines Sales Market Share in Global Market
Table Novartis International Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Sanofi Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table Sanofi Meningococcal Vaccines Sales Market Share in Global Market
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Pfizer Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table Pfizer Meningococcal Vaccines Sales Market Share in Global Market
Table Pfizer Recent Development
Table Baxter International Company Details
Table Baxter International Description and Business Overview
Table Baxter International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2020)
Table Baxter International Meningococcal Vaccines Sales Growth Rate (2016-2020)
Table Baxter International Meningococcal Vaccines Sales Market Share in Global Market
Table Baxter International Recent Development
Figure Meningococcal Vaccines Value Chain
Table Meningococcal Vaccines Distributors List
Table Meningococcal Vaccines Customers List
Table Global Meningococcal Vaccines Sales Forecast 2021-2027 (K Units) & (Million US$)
Figure Global Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Table Global Meningococcal Vaccines Sales Forecast by Type 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Forecast by Type 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Market Share Forecast by Type 2021-2027
Table Global Meningococcal Vaccines Sales Forecast by Application 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Forecast by Application 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Market Share Forecast by Application 2021-2027
Table Global Meningococcal Vaccines Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Forecast by Regions 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Sales Market Share Forecast by Regions 2021-2027
Table Global Meningococcal Vaccines Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Revenue Forecast by Regions 2021-2027 (K Units)
Figure Global Meningococcal Vaccines Revenue Market Share Forecast by Regions 2021-2027
Figure United States Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure United States Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure European Union Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure European Union Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure China Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure China Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure Japan Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure Japan Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure Korea Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure Korea Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure India Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure India Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Meningococcal Vaccines Sales Forecast 2021-2027 (K Units)
Figure Southeast Asia Meningococcal Vaccines Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources